News

Institute launches a new AI initiative to power biological research

Rachel Scanza
By Rachel Scanza
Dec. 14, 2024

With artificial intelligence (AI) poised to greatly accelerate the pace for novel discoveries in foundational biological research, the Stowers Institute launched the Office of Scientific Leadership AI Initiative, a new program designed to advance capabilities in machine learning and AI for addressing critical biological questions. Investigator Julia Zeitlinger, Ph.D., has been appointed to lead this effort and leverage cutting-edge computational techniques to accelerate scientific discoveries and drive innovation in biological research.

From left to right: Julia Zeitlinger, Ph.D., Jay Unruh, Ph.D., and Evelyn Travnik
From left to right: Julia Zeitlinger, Ph.D., Jay Unruh, Ph.D., and Evelyn Travnik

Zeitlinger will work to develop and execute a long-term strategy to build world-class AI-powered computational expertise. She will head the steering committee that, together with Chief Information Officer Evelyn Travnik and Director of Scientific Data Jay Unruh, Ph.D., prioritizes and implements computational efforts across the organization. She also advises the Stowers Fellows program and the Graduate School to attract, support, and maintain computational talent at the Institute.

“Biology is incredibly complex, and AI is an excellent way to detect the underlying patterns and rules. A great example is the information encoded in our DNA, how it us used to create gene products like proteins, and how those gene products function to support life,” said Zeitlinger. “I am passionate about leading the Institute’s new initiative to promote AI in our scientific research. It is both an exciting challenge and a huge opportunity.”

A fundamental biological quest is to understand how variations within our genetic code and the molecules arising from it not only make us unique but can also underlie disease or disease susceptibility. AI’s predictive capabilities can guide targeted experimental approaches to identify how these variations impact gene regulation and protein function, key factors governing development, health, and disease.

“Many of our investigators including Zeitlinger and our Technology Center scientists are engaged in the pursuit of understanding how sequences within our DNA genetic blueprint control gene activity and how the shape of proteins affects their function,” said Stowers Scientific Director Kausik Si, Ph.D.

“Leveraging the power of AI will enable researchers Institute-wide to answer questions that remain some of the biggest biological mysteries for the benefit of all,” said Stowers President and Chief Scientific Officer Alejandro Sánchez Alvarado, Ph.D.

This article is republished from Stowers News. Read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Rachel Scanza
Rachel Scanza

Rachel Scanza is a senior science writer at the Stowers Institute for Medical Research, where she translates complex science for a broad audience to author press releases, news stories, and features. Scanza earned a Ph.D. in atmospheric science from Cornell University and continued to investigate atmospheric aerosols on climate as a postdoctoral fellow at Pacific Northwest National Laboratory.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Glaucoma model links immune signaling to disease progression
Journal News

Glaucoma model links immune signaling to disease progression

June 4, 2026

Researchers at Duke University determine genetic variations that could increase the risk of developing glaucoma.

Uncovering the molecular roots of fatty liver disease
Interview

Uncovering the molecular roots of fatty liver disease

June 3, 2026

Physician–scientist Silvia Sookoian discusses her path from hepatitis C care to MASLD research, her use of multi-omics to study steatotic liver disease, and how lipid metabolism and genetics are reshaping understanding of MASH and liver health.

Mitochondria shape kidney cell function
Journal News

Mitochondria shape kidney cell function

May 28, 2026

Researchers at the University of Washington, Seattle present the first quantitative comparison of mitochondrial interactomes between two epithelial cell types in the kidney.

Long-chain polyunsaturated fatty acids linked to postoperative delirium risk
Journal News

Long-chain polyunsaturated fatty acids linked to postoperative delirium risk

May 27, 2026

Researchers show that altered lipid metabolism may contribute to postoperative delirium, a condition linked to increased risk for long-term cognitive decline. The study explores potential disease mechanisms, which have yet to be understood.

Glycosylation patterns across antibody isotypes distinguish tuberculosis states
Journal News

Glycosylation patterns across antibody isotypes distinguish tuberculosis states

May 26, 2026

Researchers at Taipei Medical University present the first site-specific glycosylation analysis of immunoglobulins in elderly tuberculosis patients.

Blood glycome possibly predicts lifespan
Journal News

Blood glycome possibly predicts lifespan

May 21, 2026

Researchers at the University of Santiago de Compostela show that total serum N-glycome can predict mortality independent of traditional risk factors.